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Coinciding with the release of the fifth edition of the
Diagnostic and Statistical Manual of Mental Disorders,
two recently published molecular genetics analyses
suggest large overlaps in genetic liability to
schizophrenia, bipolar disorder and major depressive
disorder. This indicates that a broader category of
severe mental illness may be an important target for
future large-scale etiological and therapeutic
investigations. Studies of patient groups not restricted
to current diagnostic categories may lead to a
genetically informed nosology.mental illness runs in families, and twin studies have
produced heritability estimates ranging from 0.37 to 0.90Introduction
The year 2013 may be a turning point in the history of
psychiatry. In May 2013, the American Psychiatric Asso-
ciation published the fifth edition of the Diagnostic and
Statistical Manual of Mental Disorders (DSM-5) [1]. In
April and September 2013, the Psychiatric Genomics
Consortium (PGC) published key reports on the genetic
relationships between five major psychiatric disorders
[2,3]. A comparison of these publications highlights is-
sues that psychiatry will have to grapple with in the next
decade.
Genetics is one of the major sources of information on
the classification of mental illness. Unlike cognitive or
neuroimaging measurements, genetic information is
stable across an individual’s life and can be interpreted
as a cause rather than a consequence of psychopath-
ology. For decades, information on the genetic contribu-
tion to liability and genetic relationships between
disorders was derived indirectly from family, twin and
adoption studies. With the application of genomic ap-
proaches, it is now possible to estimate the magnitude of
the genetic contribution and the degree of relatednessCorrespondence: uher@dal.ca
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Canada
© 2013 BioMed Central Ltd.between disorders directly from molecular data. The re-
sults of these analyses are not without surprises. Here, I
discuss the new findings and their implications for the
classification of psychiatric disorders.Mental illness: not as heritable as we thought?
The first finding of the recent PGC studies [2,3] con-
cerns the overall magnitude of the genetic contribution
to mental illness. This is typically indexed as heritability,
a measure ranging from 0 to 1 that reflects the propor-
tion of differences between people that are attributable
to genetic factors. It has been known for decades that
[4]. Researchers from the PGC have used a new method
to estimate heritability from molecular genetic data. By
comparing the overall number of genetic similarities be-
tween patients with an illness to the number of genetic
similarities between patients and controls, they esti-
mated that common genetic variants contributed be-
tween 17% and 29% of the variation in liability to mental
illness, approximately one-third of the heritability esti-
mates derived from twin studies (Figure 1a) [2]. It is also
less than heritability estimates for non-disorder pheno-
types, such as the response to antidepressants or
reported stressful life events obtained with the same mo-
lecular method [5,6]. The discrepancy between molecu-
lar and twin estimates may be partly because some of
the risk is carried by rare genetic variants that are only
partly tagged by the measured common variants. The
large differential between twin and molecular estimates
of heritability for autism spectrum disorders, for which a
large contribution of rare genetic variants is likely, sug-
gests that this might be the case [4]. However, it is also
likely that twin studies overestimated heritability by as-
suming that monozygotic twins share a common envir-
onment in a similar way to dizygotic twins, and by
including gene-environment interactions (those involv-
ing shared aspects of environment) in estimates of herit-
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Genetic relationships between disorders.Heritability estimates from twin and molecular data.
Key:
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Figure 1 Heritability and genetic relationships between psychiatric disorders. (a) Heritability estimates from twin studies (blue bars)
contrasted with heritability estimates from molecular data on single nucleotide polymorphisms (SNPs; pink bars). (b) Genetic relatedness between
disorders as estimated from molecular SNP data: the length of the dashed lines corresponds to the degree of genetic relatedness (shorter line =
more closely related disorders) and the blue numbers next to the line are genetic correlations estimated from molecular SNP data. The pink circle
represents the extent of the proposed broader category of severe mental illness that encompasses the more closely related disorders. ADHD,
attention-deficit/hyperactivity disorder; ASD, autism spectrum disorder; BPD, bipolar disorder; MDD, major depressive disorder; SCH, schizophrenia;
SMI, severe mental illness (broad category); SNP, single nucleotide polymorphism.
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when using twin studies to inform nosology.
Relationships between psychiatric disorders: time
to re-focus on broader categories
One of the changes in DSM-5 was the separation of
‘mood disorders’ into two chapters, one on bipolar and
the other on depressive disorders. The PGC has shown
that there are more genetic similarities than differences
between mood and psychotic disorders. Schizophrenia
shared 68% of genetic liability with bipolar disorder and
43% of genetic liability with depression. Bipolar disorder
and depression shared 47% of the genetic disposition
(Figure 1b) [2]. Four specific genetic variants were inde-
pendently associated with two or more of these disor-
ders, but not a single one was differentially associated
with one disorder as opposed to others [3]. A recent
meta-analysis of family studies corroborates these results
by showing that familial risk goes beyond the disorder
diagnosed in a relative and extends to all types of mood
and psychotic disorders [7]. The fact that bipolar dis-
order has more genetic overlap with schizophrenia than
with depression justifies the placement in the DSM-5 of
bipolar as a separate chapter between psychotic and
mood disorders. However, the large commonality among
all three disorders (which is apparent in both molecular
and family study data) is not reflected in the DSM-5.
This suggests that both etiological investigations and
intervention studies may benefit by broadening thescope beyond single DSM categories to focus on com-
mon factors across disorders. It may be more inform-
ative to target broader categories, such as severe mental
illness, which encompasses all major mood and psych-
otic disorders that typically start in late adolescence or
young adulthood and are severe enough to require spe-
cialist psychiatric care.
Other broad categories are less well supported by mo-
lecular genetic data: DSM-5 has introduced a grouping
of ‘neurodevelopmental disorders’ that includes autism
spectrum disorders (ASD) and attention-deficit/hyper-
activity disorder (ADHD). The assumption behind this
grouping was that the etiologies of these disorders are
related, but the PGC found no detectable overlap be-
tween the genetic liability to ASD and ADHD [2,3]. The
fact that the molecular measurements were limited to
common genetic variants leaves the option open that
specific rare variants may contribute to both ASD and
ADHD. However, since the common variants carry at
least some information about rare genetic variants
(through linkage disequilibrium), the lack of any detect-
able overlap presents a challenge to including ASD and
ADHD in a single grouping and suggests that their eti-
ologies may need to be studied separately.
The new molecular analyses also inform the continuity
between child and adult disorders. One major issue that
DSM-5 had to deal with was the surge in diagnoses of
childhood bipolar disorder based on relaxed DSM-IV
criteria, including non-episodic irritability and ADHD
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criteria for bipolar disorder do not include such presen-
tations; instead, a new diagnostic category, disruptive
mood dysregulation disorder, has been created, which
covers chronic irritability in children and is included
among depressive disorders. These DSM-5 decisions are
supported by the PGC finding of no genetic overlap be-
tween ADHD and bipolar disorder [2,3]. This contrasts
with family studies, which found overlapping familial
risks for bipolar disorder and ADHD [7,8]. The discrep-
ancy between molecular and family studies implicates
reasons other than common genetic variants for the co-
occurrence of ADHD and bipolar disorder in families.
Somewhat surprisingly, a significant overlap was found
between ADHD and major depressive disorder. This is
in agreement with a meta-analysis of family studies that
found that the risk of ADHD was elevated to a greater
extent among offspring of parents with major depressive
disorder than among offspring of parents with bipolar
disorder [7].
Distinctiveness of disorders and number of
categories: the need to study unselected patient
groups
DSM-5 continues a trend of producing an increasing
number of disorders by splitting and creating new cat-
egories. The PGC took five of the most distinctive dis-
orders and showed that there were more genetic
similarities than differences between them [3]. This is
yet more evidence of the limited validity of DSM cat-
egories [9]. Most available evidence suggests that having
relatively few broader categories may be more useful
than the current DSM classification in both research
and clinical settings [10]. The alternative approach is a
dimensional classification. This was rejected late in the
DSM-5 development because there was no consensus
on how many and which dimensions are needed and
how they could be practically applied in clinical settings
[1,10]. While the PGC cross-disorder analyses are in-
formative in many ways, they may not help with the
biggest question: how many categories or dimensions
are needed to classify psychopathology. The PGC re-
ports were based on a collection of case–control stud-
ies, each of which started with a DSM category. In a
typical case–control study, participants who fulfill the
criteria for a specific disorder are classified as cases,
those who are relatively free of psychopathology as con-
trols, and those who fulfill criteria for other disorders
or fall in between are excluded. Without including the
latter individuals - those who fall in between the criteria
for disorders - in investigations, we cannot expect a
major advance in psychiatric classification [10]. Some of
the most remarkable discoveries in psychiatry, includ-
ing the use of lithium for bipolar disorder andstimulants for ADHD, started with investigations of un-
selected patient groups. These discoveries may have
been missed had the initial study focused on a single
DSM-type category. Modern molecular genetics pro-
vides the tools to inform psychiatric classification in
novel ways, free of assumptions and historical baggage.
To do this, it needs large samples of individuals with
mental illness that were not pre-selected based on a
previous classification that is known to be of limited
validity [4,10]. Investigation of such unselected groups
coupled with emerging genomic methods, such as new
generation sequencing, has the potential to create a
classification derived from genomic data. The contrast
between DSM-5 and molecular genetic cross-disorder
analyses could make 2013 the starting point for new
psychiatric science.
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